Skip to content

Clinical trials

Active, not recruiting Small Cell Lung Carcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Active, not recruiting Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20182
20204
20214
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Merck Sharp & Dohme LLC3
National Cancer Institute (NCI)2
23andMe, Inc.1
AstraZeneca1
British Columbia Cancer Agency1
Klus Pharma Inc.1
NRG Oncology1
SWOG Cancer Research Network1
Theratechnologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma15
Carcinoma, Ovarian Epithelial3
Neuroendocrine Tumors3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Lung Neoplasms2
Triple Negative Breast Neoplasms2
Brain Neoplasms1
Carcinoid Tumor1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.